Saltar al contenido
Merck
  • Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2013-06-05)
Sonia Burrel, David Boutolleau, Georges Azar, Serge Doan, Claire Deback, Isabelle Cochereau, Henri Agut, Eric E Gabison
RESUMEN

Herpes simplex virus type 1 (HSV-1) is a leading cause of corneal blindness. Acyclovir (ACV) constitutes the standard treatment of HSV infections including herpetic keratitis (HK). HSV resistance to ACV is mainly described in immunocompromised patients. We describe two cases of ACV-resistant corneal HSV-1 in immunocompetent individuals with recurrent HK.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acycloguanosine, ≥99% (HPLC), powder
Aciclovir, European Pharmacopoeia (EP) Reference Standard